About us

Trichy Research Institute of Biotechnology Pvt. Ltd (TRI Biotech) is an ISO certified contract research and industrial training institute, founded with a noble vision to help and develop rural students with scientific advancement in the field of life sciences. TRI Biotech was established in the year of 2016 at the heart of the Tiruchirappalli city (Thillai Nagar) as a proprietary firm and registered under MSME as Trichy Research Center for Biotechnology (TRCBT). Meanwhile, TRI Biotech has made significant progression in teaching, hands on training programs, workshops, contract research and development. Trichy Research Center for Biotechnology became a private limited company in the year of 2017 and registered under an Indian companies act 2013 and CIN of the company is U73200TN2017PTC119075.

TRI Biotech has been established to provide in-depth practical knowledge in life sciences and preparing students for their future job options with quality benefits. We encourage innovative young minds to develop their dream projects and ideas to become true, by providing scholarly guidance, facilities, and support. TRI Biotech is committed to creation of research knowledge through hands on training programs and research projects in the field of life sciences such as biomedical, zoology, biotechnology, microbiology, molecular biology and biochemistry.

Our cutting edge research areas

Focus

Trichy Research Institute of Biotechnology (P) Ltd (TRI Biotech) is committed to creation of research knowledge through hands on training programs and research projects

Mission

To provide excellent research facility

Create quality human resources for scientific research

Publish high quality research papers in reputed journals

Vision

To Make TRI Biotech a renowned research institute

Bringing prosperity to India by sharing research knowledge.

To meet global needs through biotechnology

Publications

Publication details

• Angel Jemima E, Prema A, Berla Thangam E (2014). Functional Characterization of Histamine H4 Receptor on human mast cells. Molecular Immunology. 62, 19-28. (Impact factor: 3.0). (PMID: 24934979).

• Angel Jemima E, Manoharan S, Kumanan K (2014). Development and evaluation of a recombinant-glycoprotein-based latex agglutination test for rabies virus antibody assessment. Archives of Virology.159, 1987-1993. (Impact factor: 2.39). (PMID: 24590567)

• Angel Jemima E, Berla Thangam E, Prema A (2016). H4R activation utilizes distinct signaling pathways for the production of RANTES and IL-13 in human mast cells. Journal of Receptors and Signal Transduction. 37(2):133-140. (Impact factor: 2.2). (PMID: 27400655)

• Angel Jemima E, Kavya Prasad, SanjanaRajan, Prema A. Berla Thangam E. (2017). Silencing of H4R inhibits the production of IL-1β through SAPK/JNK signaling in human mast cells. Journal of Receptors and Signal Transduction. 37(2):133-140. (Impact factor: 2.2). (PMID: 29863427)

• Berla Thangam E, Angel Jemima E, Mahajbin Khan, Mirza Saquib Bag, Clinton B Mathias, Rohit Saluja (2018). The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Frontiers In Immunology. 2018 Aug 13;9:1873. (Impact factor: 5.5). (PMID: 30150993)

• Anupam Prakash, Angel Jemima Ebenezer, Sugitharini Vasanth, Gomathi Nagarajan, Berla Thangam Elden (2017). Effect of Ocimumtenuiflorum Linn Extract on Histamine Mediated Allergic Inflammation in Human Mast Cells. Journal of Biologically active products from nature. 7(1): 10-17.